171 related articles for article (PubMed ID: 16246405)
1. Prevalence and prognostic significance of COX-2 expression in stage IB cervical cancer.
Manchana T; Triratanachat S; Sirisabya N; Vasuratna A; Termrungruanglert W; Tresukosol D
Gynecol Oncol; 2006 Mar; 100(3):556-60. PubMed ID: 16246405
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Ruangvejvorachai P; Thorner PS; Siriaunkgul S
Gynecol Oncol; 2009 Jan; 112(1):241-7. PubMed ID: 18977022
[TBL] [Abstract][Full Text] [Related]
3. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
4. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
[TBL] [Abstract][Full Text] [Related]
5. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion.
Ryu HS; Chang KH; Yang HW; Kim MS; Kwon HC; Oh KS
Gynecol Oncol; 2000 Mar; 76(3):320-5. PubMed ID: 10684704
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
7. Expression of thymidine phosphorylase in human cervical cancer.
Hata K; Takebayashi Y; Iida K; Fujiwaki R; Fukumoto M; Miyazaki K
Anticancer Res; 1999; 19(1B):709-16. PubMed ID: 10216481
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
9. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939
[TBL] [Abstract][Full Text] [Related]
10. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
[TBL] [Abstract][Full Text] [Related]
11. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy.
Inaba T; Ino K; Kajiyama H; Shibata K; Yamamoto E; Kondo S; Umezu T; Nawa A; Takikawa O; Kikkawa F
Gynecol Oncol; 2010 Jun; 117(3):423-8. PubMed ID: 20350764
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
[TBL] [Abstract][Full Text] [Related]
14. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.
Chen Y; Xu H; Li Y; Wang D; Li J; Yuan J; Liang Z
Ann Surg Oncol; 2008 Oct; 15(10):2847-55. PubMed ID: 18649105
[TBL] [Abstract][Full Text] [Related]
15. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy.
Kodama J; Seki N; Nakamura K; Hongo A; Hiramatsu Y
Gynecol Oncol; 2007 Jun; 105(3):757-61. PubMed ID: 17433424
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy.
Chen HH; Su WC; Chou CY; Guo HR; Ho SY; Que J; Lee WY
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1093-100. PubMed ID: 16099602
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy.
Pyo H; Kim YB; Cho NH; Suh CO; Park TK; Yun YS; Kim GE
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):725-32. PubMed ID: 15936552
[TBL] [Abstract][Full Text] [Related]
19. Missing association between telomerase activity and clinicopathological features in patients with early stage carcinoma of the cervix.
Santos-Filho AS; Triginelli SA; Traiman P; Cunha-Melo JR; Silva-Filho AL
Arch Gynecol Obstet; 2007 Jan; 275(1):13-7. PubMed ID: 16858573
[TBL] [Abstract][Full Text] [Related]
20. The 72-kDa metalloproteinase immunostaining in cervical carcinoma: relationship with lymph nodal involvement.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Romanini C; Biagini G
Gynecol Oncol; 1996 Feb; 60(2):271-6. PubMed ID: 8631550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
